Showing results (341-350 of 423) with videos related to
Sort By:
Pageof 43
Schizophrenia Research|April 17, 2013
Symptom dimensions and functional impairment in early psychosis: more to the story than just negative symptomsDaniel Fulford, Tara A Niendam, Erin G Floyd, et al.Blood|March 1, 1980
Regulation of hematopoiesis: helper and suppressor influences of the thymusS J Sharkis, J L Spivak, A Ahmed, et al.Transfusion|March 13, 2012
Pegfilgrastim- versus filgrastim-based autologous hematopoietic stem cell mobilization in the setting of preemptive use of plerixafor: efficacy and cost analysisLuciano J Costa, Cindy Kramer, Kathy R Hogan, et al.Experimental Hematology|September 30, 2009
Hematopoietic stem cell origin of human fibroblasts: cell culture studies of female recipients of gender-mismatched stem cell transplantation and patients with chronic myelogenous leukemiaKeisuke Shirai, Yasuhiko Sera, William Bulkeley, et al.Psychological Medicine|March 15, 2021
Thalamic dysconnectivity in the psychosis risk syndrome and early illness schizophreniaSusanna L Fryer, Jamie M Ferri, Brian J Roach, et al.Brain Connectivity|June 2, 2018
Transient Patterns of Functional Dysconnectivity in Clinical High Risk and Early Illness Schizophrenia Individuals Compared with Healthy ControlsEva Mennigen, Susanna L Fryer, Barnaly Rashid, et al.Standards in Genomic Sciences|August 26, 2016
Permanent draft genome of strain ESFC-1: ecological genomics of a newly discovered lineage of filamentous diazotrophic cyanobacteriaR Craig Everroad, Rhona K Stuart, Brad M Bebout, et al.Transfusion|March 12, 2011
Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft functionErin T Alexander, Jeanne A Towery, Ashley N Miller, et al.The American Surgeon|July 1, 1987
Potent immunosuppression overcomes immunologic high-risk factors in recipients of cadaveric renal allograftsA O Gaber, J R Thistlethwaite, B W Haag, et al.Pageof 43